IGM Biosciences, Inc. (IGMS)

IGM Biosciences Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Jun 30, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Cash & Equivalents	30.65	26.5	112.52	121.23	133.33	241.08
Short-Term Investments	73.66	157.29	225.16	305.93	96.21	125.19
Cash & Short-Term Investments	104.31	183.79	337.68	427.16	229.54	366.27
Cash Growth	-59.32%	-45.57%	-20.95%	86.09%	-37.33%	63.05%
Other Receivables	0.5	0.8	0.8	0.5	-	-
Receivables	0.5	0.8	0.8	0.5	-	-
Prepaid Expenses	2.18	8.87	8.53	10.07	10.5	7
Restricted Cash	-	0.17	0.59	0.69	0.7	-
Total Current Assets	106.99	193.62	347.6	438.42	240.75	373.27
Property, Plant & Equipment	-	71.03	74.01	73.08	56.34	34.81
Other Long-Term Assets	-	1.06	1.81	2	1.04	0.55
Total Assets	106.99	265.71	423.41	513.5	298.13	408.63
Accounts Payable	2.4	0.98	1.33	2.51	5.58	7.92
Accrued Expenses	3.66	26.88	31.54	33.62	18.88	6.65
Current Portion of Leases	-	7.12	5.83	5.82	3.32	2.67
Current Unearned Revenue	-	2.65	3.78	2.74	-	-
Total Current Liabilities	6.06	37.64	42.48	44.69	27.78	17.24
Long-Term Leases	-	38.07	34.67	35.36	25.44	9.58
Long-Term Unearned Revenue	-	141.47	143.02	146.2	-	-
Other Long-Term Liabilities	-	0.37	-	-	-	-
Total Liabilities	6.06	217.54	220.18	226.24	53.22	26.82
Common Stock	0.6	0.6	0.59	0.43	0.33	0.32
Additional Paid-In Capital	1,073	1,064	1,024	862.36	598.37	570.03
Retained Earnings	-972.35	-1,017	-821.24	-574.83	-353.72	-188.56
Comprehensive Income & Other	0.01	0.16	0.15	-0.7	-0.07	0.03
Total Common Equity	100.93	48.17	203.23	287.26	244.91	381.82
Shareholders' Equity	100.93	48.17	203.23	287.26	244.91	381.82
Total Liabilities & Equity	106.99	265.71	423.41	513.5	298.13	408.63
Total Debt	-	45.19	40.51	41.17	28.76	12.24
Net Cash (Debt)	104.31	138.6	297.17	385.99	200.78	354.03
Net Cash Growth	-51.93%	-53.36%	-23.01%	92.24%	-43.29%	68.66%
Net Cash Per Share	1.71	2.29	5.68	9.29	6.00	11.51
Filing Date Shares Outstanding	60.29	59.78	58.79	43.18	32.51	32.01
Total Common Shares Outstanding	60.19	59.65	58.68	43.08	32.5	31.97
Working Capital	100.93	155.98	305.12	393.74	212.97	356.03
Book Value Per Share	1.68	0.81	3.46	6.67	7.54	11.94
Tangible Book Value	100.93	48.17	203.23	287.26	244.91	381.82
Tangible Book Value Per Share	1.68	0.81	3.46	6.67	7.54	11.94
Machinery	-	36.66	35.12	26.26	18.35	7.34
Construction In Progress	-	1.01	5.8	5.11	2.53	17.93
Leasehold Improvements	-	24.16	17.91	14.43	14.17	0.25

Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q